Return On Assets of Lyell Immunopharma, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lyell Immunopharma, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Lyell Immunopharma, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -76%, a 153% decline year-over-year.
  • Lyell Immunopharma, Inc. annual Return On Assets for 2024 was -56%, a 94% decline from 2023.
  • Lyell Immunopharma, Inc. annual Return On Assets for 2023 was -29%, a 58% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Lyell Immunopharma, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -76% -46% -153% 01 Jul 2025 30 Sep 2025
Q2 2025 -69% -40% -137% 01 Apr 2025 30 Jun 2025
Q1 2025 -61% -31% -105% 01 Jan 2025 31 Mar 2025
Q4 2024 -56% -27% -94% 01 Oct 2024 31 Dec 2024
Q3 2024 -30% -8% -36% 01 Jul 2024 30 Sep 2024
Q2 2024 -29% -6% -26% 01 Apr 2024 30 Jun 2024
Q1 2024 -30% -11% -56% 01 Jan 2024 31 Mar 2024
Q4 2023 -29% -11% -58% 01 Oct 2023 31 Dec 2023
Q3 2023 -22% +3% +10% 01 Jul 2023 30 Sep 2023
Q2 2023 -23% -2% -7.6% 01 Apr 2023 30 Jun 2023
Q1 2023 -19% +4% +16% 01 Jan 2023 31 Mar 2023
Q4 2022 -18% 01 Oct 2022 31 Dec 2022
Q3 2022 -25% 01 Jul 2022 30 Sep 2022
Q2 2022 -21% 01 Apr 2022 30 Jun 2022
Q1 2022 -23% 01 Jan 2022 31 Mar 2022

Lyell Immunopharma, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -56% -27% -94% 01 Jan 2024 31 Dec 2024
2023 -29% -11% -58% 01 Jan 2023 31 Dec 2023
2022 -18% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.